Abstract 68: The WWOX Gene Modulates HDL Metabolism and Lipoprotein Gene Expression
Low plasma HDL cholesterol (HDL-C) constitutes a major risk factor for coronary artery disease. We previously identified a region-wide association between low HDL-C and the WW domain-containing oxidoreductase (WWOX) gene in dyslipidemic families and low HDL-C cases and controls (rs2548861, P=6.9x10-7). Here, through a combination of in vivo functional studies, gene microarray and next generation resequencing, we investigated the role of WWOX in lipoprotein and HDL metabolism. Using total Wwox-/- and Wwox liver-specific (hep-/-) mice, we found decreased apoA-I and ABCA1 protein levels in hepatic tissues. Analyses of lipoprotein profiles in Wwox-/- littermates also showed marked reductions in serum HDL-C and apoA-I levels, with no effect in Wwox hep-/- mice. A sex-specific difference was however observed in female Wwox hep-/- mice, showing a significant increase in plasma triglycerides levels. We further obtained evidence of a gender-specific effect by gene microarray analyses in Wwox hep-/- hepatocytes, where it was identified that WWOX disruption alters primarily lipid metabolic pathways in females. We observed a significant reduction (P<0.05,
- © 2013 by American Heart Association, Inc.